Vimarsana
Biggest News Aggregation in the World

Page 27 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Pharma Today - Breaking & Trending Today

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active...

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets - Vimarsana News

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets

CHICAGO, Oct. 6, 2021 /PRNewswire/ -- According to the new market research report "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Pharmaceutical Contract Development and Manufacturing Market worth $171.3 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active...

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site - Vimarsana News

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

/PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, today...

Small Pharma accelerate key psychedelic trial for the treatment of depression - Vimarsana News

Small Pharma accelerate key psychedelic trial for the treatment of depression

Small Pharma’s (CVE:DMT) Carol Routledge, Chief Medical and Scientific Officer joins Proactive London’s Katie Pilbeam to discuss their specialism in...